Aeglea BioTherapeutics Inc (AGLE):企業の財務・戦略的SWOT分析

◆英語タイトル:Aeglea BioTherapeutics Inc (AGLE) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH500853FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥90,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥135,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aeglea BioTherapeutics Inc (Aeglea), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company. The company develops and commercializes human enzymes for the treatment of cancer and rare genetic diseases. The company’s lead product pipeline includes pegzilarginase (AEB1102), is used for the treatment of arginase deficiency. It also develops ACN00177, for treating classical homocystinuria, a rare disease cause due to hereditary genetic deficiency. Aeglea also provides enzyme solutions to treat diseases with unmet medical needs. The company works in partnership with research institutions, healthcare providers and pharmaceutical companies. It caters its products across the US and the UK. Aeglea is headquartered in Austin, Texas, the US.

Aeglea BioTherapeutics Inc Key Recent Developments

Mar 18,2021: Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights
Feb 24,2021: Aeglea BioTherapeutics appoints Sara Brownstein to Board of Directors
Feb 04,2021: Aeglea BioTherapeutics Announces Transition of Chief Financial Officer
Feb 03,2021: Aeglea BioTherapeutics announces transition of Chief Financial Officer
Dec 17,2020: Aeglea BioTherapeutics appoints Alison Lawton to board of directors

This comprehensive SWOT profile of Aeglea BioTherapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aeglea BioTherapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Aeglea BioTherapeutics Inc – Key Information
Aeglea BioTherapeutics Inc – Overview
Aeglea BioTherapeutics Inc – Key Employees
Aeglea BioTherapeutics Inc – Key Employee Biographies
Aeglea BioTherapeutics Inc – Key Operational Heads
Aeglea BioTherapeutics Inc – Major Products and Services
Aeglea BioTherapeutics Inc – History
Aeglea BioTherapeutics Inc – Company Statement
Aeglea BioTherapeutics Inc – Locations And Subsidiaries
Aeglea BioTherapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Aeglea BioTherapeutics Inc – Business Description
Aeglea BioTherapeutics Inc – Corporate Strategy
Aeglea BioTherapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Aeglea BioTherapeutics Inc – Strengths
Aeglea BioTherapeutics Inc – Weaknesses
Aeglea BioTherapeutics Inc – Opportunities
Aeglea BioTherapeutics Inc – Threats
Aeglea BioTherapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Aeglea BioTherapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Aeglea BioTherapeutics Inc, Key Information
Aeglea BioTherapeutics Inc, Key Ratios
Aeglea BioTherapeutics Inc, Share Data
Aeglea BioTherapeutics Inc, Major Products and Services
Aeglea BioTherapeutics Inc, History
Aeglea BioTherapeutics Inc, Key Employees
Aeglea BioTherapeutics Inc, Key Employee Biographies
Aeglea BioTherapeutics Inc, Key Operational Heads
Aeglea BioTherapeutics Inc, Other Locations
Aeglea BioTherapeutics Inc, Subsidiaries
Aeglea BioTherapeutics Inc, Key Competitors
Aeglea BioTherapeutics Inc, SWOT Analysis
Aeglea BioTherapeutics Inc, Ratios based on current share price
Aeglea BioTherapeutics Inc, Annual Ratios
Aeglea BioTherapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Aeglea BioTherapeutics Inc (AGLE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ben E. Keith Company:戦略・SWOT・企業財務分析
    Ben E. Keith Company - Strategy, SWOT and Corporate Finance Report Summary Ben E. Keith Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Lanka IOC PLC (LIOC.N0000):企業の財務・戦略的SWOT分析
    Summary Lanka IOC Plc (LIOC), a subsidiary of Indian Oil Corporation Ltd is an oil and gas company that imports, sells and distributes petroleum products. The company's products include lubricants, fuels, bitumen and bunkering products. It provides automotive lubricants, including passenger car, die …
  • Service Corporation International (SCI):企業の財務・戦略的SWOT分析
    Service Corporation International (SCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Standard Bank Group Limited:企業の戦略・SWOT・財務分析
    Standard Bank Group Limited - Strategy, SWOT and Corporate Finance Report Summary Standard Bank Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sirona Biochem Corp (SBM):企業の財務・戦略的SWOT分析
    Summary Sirona Biochem Corp (Sirona Biochem) is a biotechnology company that discovers and develops therapeutics, cosmeceuticals and biological ingredients. The company develops drugs for diabetes and cancer. It offers cosmeceutical programs such as development of anti-aging and depigmenting agents, …
  • Hyduke Energy Services Inc (HYD):石油・ガス:M&Aディール及び事業提携情報
    Summary Hyduke Energy Services Inc. (Hyduke) is an integrated oilfield services company that manufacture, repair and distributes oilfield equipment and supplies. It carries out the engineering, design and manufacture of land-based drilling rigs, service rigs, coiled tubing units, pump units, cranes, …
  • American Science & Engineering, Inc.:企業の戦略・SWOT・財務情報
    American Science & Engineering, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Science & Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Vycor Medical Inc (VYCO):企業の財務・戦略的SWOT分析
    Summary Vycor Medical Inc (Vycor) is a medical device company that develops, designs, and markets medical devices for use in neurosurgery. The company offers computer-based light stimulation therapies for patients suffering from vision loss resulting from neurological trauma such as stroke. It provi …
  • Energen Corp (EGN):石油・ガス:M&Aディール及び事業提携情報
    Summary Energen Corp (Energen) is an oil and gas company that offers exploration and production programs. The company through its subsidiary, Energen Resources Corporation, is involved in the development, acquisition, exploration, and production of oil, natural gas, and natural gas liquids located i …
  • NovoCure Ltd (NVCR):企業の財務・戦略的SWOT分析
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • DMC Global Inc (BOOM):企業の財務・戦略的SWOT分析
    Summary DMC Global Inc (DMC), formerly Dynamic Materials Corp is an industrial equipment and machinery company. It manufactures, distributes, and markets explosion welded clad metal plates. The company’s products include oilfield products, explosive metalworking equipment, and AMK welding equipment, …
  • Florida Public Utilities Co:企業の戦略的SWOT分析
    Florida Public Utilities Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Edison SpA (EDNR):企業の財務・戦略的SWOT分析
    Edison SpA (EDNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • iRobot Corp (IRBT):企業の財務・戦略的SWOT分析
    iRobot Corp (IRBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • DiaGenic ASA (NEL):医療機器:M&Aディール及び事業提携情報
    Summary DiaGenic ASA (DiaGenic) is a medical device company that develops and markets blood based biomarkers for early detection of Alzheimer’s disease. The company offers MCItect, ADtect and AMYtect products. Its ADtect is a blood test that helps distinguish mild to moderate range AD from the absen …
  • BioRestorative Therapies Inc (BRTX):企業の財務・戦略的SWOT分析
    Summary BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment …
  • Korea Zinc Co Ltd (010130):企業の財務・戦略的SWOT分析
    Summary Korea Zinc Co Ltd (Korea Zinc) operates as a mineral smelting company. The company develops and acquires gold, silver, cobalt, zinc, and copper and other rare and base metal properties. It operates a production facility, Onsan Refinery in Ulju-gun region of Ulsan in South Korea. Korea Zinc’s …
  • JSP Corp (7942):企業の財務・戦略的SWOT分析
    JSP Corp (7942) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • California Pizza Kitchen, Inc.:企業の戦略的SWOT分析
    California Pizza Kitchen, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Danone SA:戦略・SWOT・企業財務分析
    Danone SA - Strategy, SWOT and Corporate Finance Report Summary Danone SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆